New data on spontaneous coronary artery dissection (SCAD), a common cause of heart attacks in younger women
New insights into spontaneous coronary artery dissection – a devastating cause of heart attacks in young, healthy patients – were presented today at the EAPCI Summit 2026.1 The summit is…
FDA approves PharmaMar’s Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-line Maintenance Therapy for Extensive-stage Small Cell Lung Cancer
harmaMar (MSE:PHM) has announced that the U.S Food and Drug Administration (FDA) has granted approval for Zepzelca® (lurbinectedin) in combination with atezolizumab (Tecentriq®) as a maintenance treatment for adults with…
Increasing potassium levels improve outcomes in patients at high risk of ventricular arrhythmia #ESCCongress #ESC25
Targeting high-normal potassium levels reduced the risk of arrhythmias, hospitalisation for heart failure or arrhythmia and death compared with no intervention, according to late-breaking research presented in a Hot Line…
New key genes in Parkinson’s disease identified using CRISPR technology
A longstanding mystery in Parkinson’s disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who…
Stem cell trial for early Alzheimer’ s disease begins at UTHealth Houston
A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway at UTHealth Houston. In Alzheimer’s disease, deposits of beta-amyloid and tau lead to…
‘BASTA UNA ZAMPA’, DOG-PET THERAPY PER RIDURRE ANSIA IN CURE PEDIATRICHE
‘All’ospedale San Paolo di Milano, presso il reparto pediatrico, è stata organizzata la prima seduta di Dog Pet Therapy del progetto nazionale ‘Basta Una Zampa’, ideato e promosso da For…
Five-minute test during routine GP appointments could prevent stroke
People at risk should be tested for atrial fibrillation every time they attend a health appointment, according to results of the AFFECT-EU project, which is holding its final event today…